• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Dry Eye Disease Market Insights, Forecast to 2025

  • RnM2418510
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report studies the global market size of Dry Eye Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dry Eye Disease in these regions.
This research report categorizes the global Dry Eye Disease market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
In 2017, the global Dry Eye Disease market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Dry Eye Disease market based on company, product type, application and key regions.

The various contributors involved in the value chain of Dry Eye Disease include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Dry Eye Disease include
Santen
Novartis
llergan
Shire
TRB Chemedica
Sun Pharmaceutical
Senju
Sentiss Pharma
Johnson & Johnson
Otsuka
Mitotech
FCI

Market Size Split by Type
Artificial Tears
Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
Punctal Plugs
Secretagogue
Market Size Split by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online pharmacies

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Dry Eye Disease market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Dry Eye Disease market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dry Eye Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Eye Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Dry Eye Disease submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Dry Eye Disease are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dry Eye Disease market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Study Coverage
1.1 Dry Eye Disease Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dry Eye Disease Market Size Growth Rate by Type
1.4.2 Artificial Tears
1.4.3 Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
1.4.4 Punctal Plugs
1.4.5 Secretagogue
1.5 Market by Application
1.5.1 Global Dry Eye Disease Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies & Drug Stores
1.5.4 Online pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dry Eye Disease Market Size
2.1.1 Global Dry Eye Disease Revenue 2016-2025
2.1.2 Global Dry Eye Disease Sales 2016-2025
2.2 Dry Eye Disease Growth Rate by Regions
2.2.1 Global Dry Eye Disease Sales by Regions
2.2.2 Global Dry Eye Disease Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Dry Eye Disease Sales by Manufacturers
3.1.1 Dry Eye Disease Sales by Manufacturers
3.1.2 Dry Eye Disease Sales Market Share by Manufacturers
3.1.3 Global Dry Eye Disease Market Concentration Ratio (CR5 and HHI)
3.2 Dry Eye Disease Revenue by Manufacturers
3.2.1 Dry Eye Disease Revenue by Manufacturers (2016-2018)
3.2.2 Dry Eye Disease Revenue Share by Manufacturers (2016-2018)
3.3 Dry Eye Disease Price by Manufacturers
3.4 Dry Eye Disease Manufacturing Base Distribution, Product Types
3.4.1 Dry Eye Disease Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dry Eye Disease Product Category
3.4.3 Date of International Manufacturers Enter into Dry Eye Disease Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Dry Eye Disease Sales by Type
4.2 Global Dry Eye Disease Revenue by Type
4.3 Dry Eye Disease Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Dry Eye Disease Breakdown Data by Application

6 North America
6.1 North America Dry Eye Disease by Countries
6.1.1 North America Dry Eye Disease Sales by Countries
6.1.2 North America Dry Eye Disease Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dry Eye Disease by Type
6.3 North America Dry Eye Disease by Application
6.4 North America Dry Eye Disease by Company

7 Europe
7.1 Europe Dry Eye Disease by Countries
7.1.1 Europe Dry Eye Disease Sales by Countries
7.1.2 Europe Dry Eye Disease Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dry Eye Disease by Type
7.3 Europe Dry Eye Disease by Application
7.4 Europe Dry Eye Disease by Company

8 Asia Pacific
8.1 Asia Pacific Dry Eye Disease by Countries
8.1.1 Asia Pacific Dry Eye Disease Sales by Countries
8.1.2 Asia Pacific Dry Eye Disease Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dry Eye Disease by Type
8.3 Asia Pacific Dry Eye Disease by Application
8.4 Asia Pacific Dry Eye Disease by Company

9 Central & South America
9.1 Central & South America Dry Eye Disease by Countries
9.1.1 Central & South America Dry Eye Disease Sales by Countries
9.1.2 Central & South America Dry Eye Disease Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dry Eye Disease by Type
9.3 Central & South America Dry Eye Disease by Application
9.4 Central & South America Dry Eye Disease by Company

10 Middle East and Africa
10.1 Middle East and Africa Dry Eye Disease by Countries
10.1.1 Middle East and Africa Dry Eye Disease Sales by Countries
10.1.2 Middle East and Africa Dry Eye Disease Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dry Eye Disease by Type
10.3 Middle East and Africa Dry Eye Disease by Application
10.4 Middle East and Africa Dry Eye Disease by Company

11 Company Profiles
11.1 Santen
11.1.1 Santen Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.1.4 Dry Eye Disease Product Description
11.1.5 Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.2.4 Dry Eye Disease Product Description
11.2.5 Recent Development
11.3 llergan
11.3.1 llergan Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.3.4 Dry Eye Disease Product Description
11.3.5 Recent Development
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.4.4 Dry Eye Disease Product Description
11.4.5 Recent Development
11.5 TRB Chemedica
11.5.1 TRB Chemedica Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.5.4 Dry Eye Disease Product Description
11.5.5 Recent Development
11.6 Sun Pharmaceutical
11.6.1 Sun Pharmaceutical Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.6.4 Dry Eye Disease Product Description
11.6.5 Recent Development
11.7 Senju
11.7.1 Senju Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.7.4 Dry Eye Disease Product Description
11.7.5 Recent Development
11.8 Sentiss Pharma
11.8.1 Sentiss Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.8.4 Dry Eye Disease Product Description
11.8.5 Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.9.4 Dry Eye Disease Product Description
11.9.5 Recent Development
11.10 Otsuka
11.10.1 Otsuka Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Dry Eye Disease
11.10.4 Dry Eye Disease Product Description
11.10.5 Recent Development
11.11 Mitotech
11.12 FCI

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Dry Eye Disease Raw Material
13.1.2 Dry Eye Disease Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Dry Eye Disease . Industry analysis & Market Report on Dry Eye Disease is a syndicated market report, published as Global Dry Eye Disease Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dry Eye Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,900.00
$7,800.00
2,618.85
5,237.70
3,588.78
7,177.56
472,446.00
944,892.00
258,622.26
517,244.52
Add To Cart Credit card Logo

Related Reports


Reason to Buy